Screening for impact of popular herbs improving mental abilities on the transcriptional level of brain transporters

1. N. J. Abbott, Blood-brain barrier structure and function and the challenges for CNS drug delivery, J. Inherit. Metab. Dis. 36 (2013) 437-449; DOI: 10.1007/s10545-013-9608-0.10.1007/s10545-013-9608-0Search in Google Scholar

2. L. A. Khawli and S. Prabhu, Drug delivery across the blood-brain barrier, Mol. Pharm. 10 (2013) 1471-1472; DOI: 10.1021/mp400170b.10.1021/mp400170bSearch in Google Scholar

3. A. H. Schinkel, J. J. Smith, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. Mol, M. A. van der Valk, E. C. Robanus-Maandag and H. P. te Riele, Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs, Cell 77 (1994) 491-502; DOI: 10.1016/0092-8674(94)90212-7.10.1016/0092-8674(94)90212-7Search in Google Scholar

4. D. S. Miller, Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier, Trends Pharmacol. Sci. 31 (2010) 246-254; DOI: 10.1016/j.tips.2010.03.003.10.1016/j.tips.2010.03.003288249620417575Search in Google Scholar

5. J. Malmo, A. Sandvig, M. K. Varum and S. P. Strand, Nanoparticle mediated P-glikoprotein silencing for improved drug delivery across the blood-brain barrier: a siRNA-chitosan approach, PLoS ONE 8 (2013) e54182; DOI: 10.1371/journal.pone.0054182.10.1371/journal.pone.0054182355312423372682Search in Google Scholar

6. F. J. Sharom, ABC multidrug transporters: structure, function and role in chemoresistance, Pharmacogenomics 9 (2008) 105-127; DOI: 10.2217/14622416.9.1.105.10.2217/14622416.9.1.10518154452Search in Google Scholar

7. C. J. Bachmeier, W. J. Trickler and D. W. Miller, Comparison of drug efflux transport kinetics in various blood-brain barrier models, Drug Metab. Dispos. 34 (2006) 998-1003; DOI: 10.1124/dmd. 105.006999.10.1124/dmdSearch in Google Scholar

8. S. P. C. Cole, Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future, Annu. Rev. Pharmacol. Toxicol. 54 (2014) 95-117; DOI: 10.1146/annurev-pharmtox-011613-135959.10.1146/annurev-pharmtox-011613-13595924050699Search in Google Scholar

9. S. A. Kliewer, The nuclear pregnane X receptor regulates xenobiotic detoxification, J. Nutr. 133 (2003) 2444S-2447S.Search in Google Scholar

10. B. I. Sikic, Modulation of multidrug resistance: at the threshold, J. Clin. Oncol. 11 (1993) 1629-1635.10.1200/JCO.1993.11.9.16298355032Search in Google Scholar

11. T. Eichhorn and T. Efferth, P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs, J. Ethnopharmacol. 141 (2012) 557-570; DOI: 10.1016/j.jep.2011.08.053.10.1016/j.jep.2011.08.05321963565Search in Google Scholar

12. O. Khantamat, W. Chaiwangyen and P. Limtrakul, Screening of flavonoids for their potential inhibitory effect on p-glycoprotein activity in human cervical carcinoma kb cells, Chiang Mai Med. Bull. 43 (2004) 45-56.Search in Google Scholar

13. S. Zhou, L. Y. Lim and B. Chowbay, Herbal modulation of P-glycoprotein, Drug Metab. Rev. 36 (2004) 57-104.10.1081/DMR-120028427Search in Google Scholar

14. P. Limtrakul, O. Khantamat and K. Pintha, Inhibition of P-glycoprotein function and expression by kaempferol and quercetin, J. Chemother. 17 (2005) 86-95; DOI: 10.1179/joc.2005.17.1.86.10.1179/joc.2005.17.1.86Search in Google Scholar

15. European Pharmacopoeia, 6th ed., Vol. 2, Council of Europe, Strassbourg Cedex 2008.Search in Google Scholar

16. T. Sugamo, K. Nakamura and H. Tamura, Effects of cytochrome P450 inducers on the gene expression of ocular xenobiotic metabolizing enzymes in rats, J. Health Sci. 55 (2009) 923-929; DOI: 10.1248/jhs.55.923.10.1248/jhs.55.923Search in Google Scholar

17. U. Andersson, K. Grankvist, A. T. Bergenheim, P. Behnam-Motlagh, H. Hedman and R. Henriksson, Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation, Med. Oncol. 19 (2002) 1-9.10.1385/MO:19:1:1Search in Google Scholar

18. R. Zhang, J. Jie, Y. Zhou, Z. Cao and W. Li, Long-term effects of Panax ginseng on disposition of fexofenadine in rats in vivo, Am. J. Chin. Med. 37 (2009) 657-667; DOI: 10.1142/S0192415X09007144.10.1142/S0192415X0900714419655405Search in Google Scholar

19. J. Zhang, F. Zhou, X. Wu, Y. Gu, H. Ai, Y. Zheng, Y. Li, X. Zhang, G. Hao, J. Sun, Y. Peng and G. Wang, 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions, Drug Metab. Dispos. 38 (2010) 2179-2187; DOI: 10.1124/dmd. 110.034793.10.1124/dmdSearch in Google Scholar

20. A. Kawase, A. Yamada, Y. Gamou, Ch. Tahara, F. Takeshita, K. Murata, H. Matsuda, K. Samukawa and M. Iwaki, Effects of ginsenosides on the expression of cytochrome P450s and transporters involved in cholesterol metabolism, J. Nat. Med. (2013); DOI 10.1007/s11418-013-0791-y.10.1007/s11418-013-0791-y23835644Search in Google Scholar

21. M. Hennessy, D. Kelleher, J. P. Spiers, M. Barry, P. Kavanagh, D. Back, F. Mulcahy and J. Feely, St Johns wort increases expression of P-glycoprotein: implications for drug interactions, Br. J. Clin. Pharmacol. 53 (2002) 75-82; DOI: 10.1046/j.0306-5251.2001.01516.x.10.1046/j.0306-5251.2001.01516.x187454411849198Search in Google Scholar

22. C. C. Weber, S. Kressmann, G. Fricker and W. E. Muller, Modulation of P-glycoprotein function by St John’s wort extract and its major constituents, Pharmacopsychiatry 37 (2004) 292-298; DOI: 10.1055/s-2004-832686.10.1055/s-2004-83268615551196Search in Google Scholar

23. Ch. Garrovo, A. Rosati, F. Bartoli and G. Decorti, St John’s wort modulation and developmental expression of multidrug transporters in the rat, Phytother. Res. 20 (2006) 468-473; DOI: 10.1002/ ptr.1880.10.1002/ptr.188016619352Search in Google Scholar

24. L. Li, J. D. Stanton, A. H. Tolson, Y. Luo and H. Wang, Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways, Pharm. Res. 26 (2009) 872-882; DOI: 10.1007/s11095-008-9788-8.10.1007/s11095-008-9788-8264969719034627Search in Google Scholar

25. G. Scambia, F. O. Ranelletti, P. B. Panici, R. De Vincenzo, G. Bonanno, G. Ferrandina, M. Piantelli, S. Bussa, C. Rumi, M. Cianfriglia and S. Mancuso, Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target, Cancer Chemoth. Pharm. 34 (1994) 459-464; DOI: 10.1371/journal.pone.0051764.10.1371/journal.pone.0051764351988623240061Search in Google Scholar

26. A. B. Shapiro and V. Ling, Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein, Biochem. Pharmacol. 53 (1997) 587-596; DOI: 10.1016/S0006-2952(96) 00826-X.Search in Google Scholar

27. M. E. Morris and S. Zhang, Flavonoid-drug interactions: Effects of flavonoids on ABC transporters, Life Sci. 78 (2006) 2116-2130; DOI: 10.1016/j.lfs. 2005.12.003. Search in Google Scholar